A. Brandi

发表

An Anatomical Substrate for the Spatiotemporal Transformation

T. Kitama, A. Grantyn, J. Petit, 1998, The Journal of Neuroscience.

Horizontal eye movement networks in primates as revealed by retrograde transneuronal transfer of rabies virus: Differences in monosynaptic input to “slow” and “fast” abducens motoneurons

W. Graf, J. Büttner-Ennever, G. Ugolini, 2006, The Journal of comparative neurology.

Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.

F. Peillon, A. Brandi, D. Joubert, 1989, The Journal of clinical endocrinology and metabolism.

Receptors and neurohormones in human pituitary adenomas.

E. Moyse, F. Peillon, A. Brandi, 1989, Hormone research.

[Neurohormones coming from the normal and tumoral human anterior pituitary. Secretion and regulation in vitro].

F. Peillon, A. Brandi, M. Feinstein, 1989, Pathologie-biologie.

Evidence of receptors for thyrotropin-releasing hormone in human prolactin-secreting adenomas.

F. Peillon, A. Brandi, M. Le Dafniet, 1983, The Journal of clinical endocrinology and metabolism.

Alterations in central neurotransmitter receptor binding sites following estradiol implantation in female rats

M. Hamon, F. Peillon, A. Brandi, 1983, Neurochemistry International.

Evidence of dopamine receptors in human growth hormone (GH)-secreting adenomas with concomitant study of dopamine inhibition of GH secretion in a perifusion system.

F. Peillon, A. Brandi, J. Racadot, 1982, The Journal of clinical endocrinology and metabolism.

Dopaminergic receptors in human prolactin-secreting adenomas: a quantitative study.

M. Martres, F. Peillon, A. Brandi, 1980, The Journal of clinical endocrinology and metabolism.

In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.

F. Peillon, A. Mauborgne, A. Brandi, 1979, The Journal of clinical endocrinology and metabolism.

[Neuropeptides of anterior pituitary origin].

P. Pagésy, F. Peillon, A. Brandi, 1991, Annales d'endocrinologie.

Organ culture of human somatotrophic pituitary adenomas: ultrastructure and growth hormone production.

F. Peillon, A. Brandi, M. Gourmelen, 1975, Acta endocrinologica.

Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.

F. Peillon, A. Brandi, M. Feinstein, 1990, The Journal of clinical endocrinology and metabolism.

Thyrotropin-releasing hormone (TRH) binding sites and thyrotropin response to TRH are regulated by thyroid hormones in human thyrotropic adenomas.

P. Chanson, F. Peillon, A. Brandi, 1994, European Journal of Endocrinology.

Prolactin secretion and synthesis in short- and long-term organ culture of pituitary tumours from acromegalic patients.

M. L'hermite, F. Peillon, M. Dubois, 1978, Acta endocrinologica.

Correlation between the number of thyroliberin binding sites, the tumour size and the plasma prolactin level in human prolactin-secreting adenomas.

P. Pagésy, F. Peillon, A. Brandi, 1985, Acta endocrinologica.

Perifusion system: its use in the study of the neuroendocrine control of human pituitary tumoral cells

F. Peillon, A. Brandi, D. Joubert, 1992, Cell Biology and Toxicology.

Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas.

F. Peillon, A. Brandi, J. Racadot, 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Density gradients of trans‐synaptically labeled collicular neurons after injections of rabies virus in the lateral rectus muscle of the rhesus monkey

Adonis Moschovakis, Werner Graf, Kostas Hadjidimitrakis, 2002, The Journal of comparative neurology.

Direct projections of omnipause neurons to reticulospinal neurons: A double‐labeling light microscopic study in the cat

N. Quenech’du, Marie-Annick Thomas, B. Kuze, 2010, The Journal of comparative neurology.

[Effect of SRIF (somatostatin) on human somatroptropic adenomas in vitro ultrastructure and growth hormone production (author's transl)(proceedings)].

P. Rivaille, F. Peillon, J. Chaussain, 1976, Annales d'endocrinologie.

In vitro and in vivo antagonistic regulation by estradiol and progesterone of the rat pituitary domperidone binding sites: correlation with ovarian steroid regulation of the dopaminergic inhibition of prolactin secretion in vitro.

P. Pagésy, F. Peillon, A. Brandi, 1985, Endocrinology.

[In vitro secretion of somatostatin (SRIH) by human adenomatous somatotropic cells. Relation with somatotropic hormone (GH) release and modulation by thyroliberin (TRH)].

F. Peillon, A. Brandi, D. Evain-Brion, 1988, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[Release of thyrotropin releasing hormone (TRH) from human prolactin-secreting pituitary adenoma cells. Modulation by dopamine].

F. Peillon, A. Brandi, M. Feinstein, 1988, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Binding of (+)-PN 200-110 to rat pituitaries and to normal and adenomatous human pituitaries

P. Chaumet‐Riffaud, F. Peillon, A. Brandi, 1987, Molecular and Cellular Endocrinology.

Changes of prolactin response to dopamine during the rat estrous cycle.

F. Peillon, A. Brandi, D. Joubert, 1990, Neuroendocrinology.

Modifications of the high and low affinity pituitary domperidone-binding sites in chronic estrogenized rats.

M. Hamon, F. Peillon, B. Kerdelhué, 1983, Endocrinology.

Effect of oestradiol on dopamine receptors and protein kinase C activity in the rat pituitary: binding of oestradiol to pituitary membranes.

F. Peillon, A. Brandi, P. Birman, 1990, Ciba Foundation symposium.